Abstract
Purpose
The intake of medications (drugs) without the knowledge of the treating physician (unknown co-medication) and nonadherence strongly influence drug safety. The aim of our study was to objectively assess unknown co-medication and nonadherence in hospitalized patients by screening urine for a large number of drugs using highly sensitive full scan gas chromatograpy/mass spectrometry (GC/MS). Secondary objectives were to determine the relationship of co-medication and nonadherence to the number of drugs prescribed and to compare history-taking by a pharmacist versus a physician.
Methods
In 152 patients, the drug histories taken by physicians, patients’ self-reported adherence, and information compiled during as many as three structured interviews conducted by a trained pharmacist on days 1–2, 3–4, and 7–11 of the hospital stay were compared with the GC/MS results from urine samples collected after each interview.
Results
In the interviews performed by the pharmacist, 235 additional drugs were identified that were not documented in the chart. Of all the drugs indicated in any interview, 16.9% were identified only by the physician, 24.1% only by the pharmacist, and 59% by both. Overall, in 78% of the patients at least one additional drug was identified by urine screening. The findings suggest overall nonadherence to at least one drug in 13.0% of patients on admission and in 23.3% of patients at any time during hospitalization. Nonadherence was less frequent for critical dose drugs and correlated with the number of prescribed drugs.
Conclusions
The drug history among hospitalized patients is often incomplete, and nonadherence and unknown co-medication are alarmingly frequent. This lack of knowledge might impact the overall success of drug therapies in the hospital setting.
Similar content being viewed by others
References
Seidling HM, Schmitt SPW, Bruckner T, Kaltschmidt J, Pruszydlo M, Senger C, Bertsche T, Walter-Sack I, Haefeli WE (2010) Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care 19:e15
Bertsche T, Bertsche A, Krieg E-M, Kunz N, Bergmann K, Hanke G, Hoppe-Tichy T, Ebinger F, Haefeli WE (2010) Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a program for nurses, physicians and parents. Qual Saf Health Care 19:e26
Carter MK, Allin DM, Scott LA, Grauer D (2006) Pharmacist-acquired medication histories in a university hospital emergency department. Am J Health Syst Pharm 63:2500–2503
Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE (2005) Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. Can Med Assoc J 30(173):510–515
Frank C, Godwin M, Verma S, Kelly A, Birenbaum A, Seguin R, Anderson J (2001) What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Phys 47:1198–1204
Bergman U, Wiholm BE (1981) Patient medication on admission to a medical clinic. Eur J Clin Pharmacol 20:185–191
Karkov LL, Schytte-Hansen S, Haugbolle LS (2010) Discrepancies between sources providing the medication histories of acutely hospitalised patients. Pharm World Sci 32:449–454
Jones HA, Metz JM, Devine P, Hahn SM, Whittington R (2002) Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology 59:272–276
Akwagyriam I, Goodyer LI, Harding L, Khakoo S, Millington H (1996) Drug history taking and the identification of drug related problems in an accident and emergency department. J Accid Emerg Med 13:166–168
Lau HS, Florax C, Porsius AJ, De Boer A (2000) The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol 49:597–603
Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M (2004) High prevalence of unknown co-medication in hospitalised patients. Eur J Clin Pharmacol 60:363–368
Schwab M, Roder F, Ammon S, Thon KP, Mörike K (1999) Increased number of hip fractures. Lancet 353:2160
Martin-Facklam M, Rieger K, Riedel K-D, Burhenne J, Walter-Sack I, Haefeli WE (2004) Undeclared exposure to St. John’s Wort in hospitalized patients. Br J Clin Pharmacol 58:437–441
Berndt S, Maier C, Schütz HW (1993) Polymedication and medication compliance in patients with chronic non-malignant pain. Pain 52:331–339
Peters FT, Drvarov O, Lottner S, Spellmeier A, Rieger K, Haefeli WE, Maurer HH (2009) A systematic comparison of four different workup procedures for systematic toxicological analysis of urine samples using gas chromatography-mass spectrometry. Anal Bioanal Chem 393:735–745
Maurer HH, Pfleger K, Weber AA (2011) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Spitzer WO (1991) Drugs as determinants of health and disease in the population. An orientation to the bridge science of pharmacoepidemiology. J Clin Epidemiol 44:823–830
Health Canada (2006) Guidance for industry: Bioequivalence requirements: critical dose drugs. Available at: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/bio/critical_dose_critique-eng.php. Accessed 31 Oct 2011
Seidling HM, Al Barmawi A, Kaltschmidt J, Bertsche T, Pruszydlo MG, Haefeli WE (2007) Detection and prevention of prescriptions with excessive doses in electronic prescribing systems. Eur J Clin Pharmacol 63:1185–1192
Laufs U, Rettig-Ewen V, Böhm M (2011) Strategies to improve drug adherence. Eur Heart J 32:264–268
Kaiser RM, Schmader KE, Pieper CF, Lindblad CI, Ruby CM, Hanlon JT (2006) Therapeutic failure-related hospitalisations in the frail elderly. Drugs Aging 23:579–586
Chan M, Nicklason F, Vial JH (2001) Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 31:199–205
Col N, Fanale JE, Kronholm P (1990) The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 150:841–845
Schmassmann-Suhijar D, Bullingham R, Gasser R, Schmutz J, Haefeli WE (1998) Rhabdomyolysis due to interaction of simvastatin with mibefradil. Lancet 351:1929–1930
Lapierre G, Leonard P (1980) L’histoire medicamenteuse acquise par le pharmacien. Can J Hosp Pharm 1:12–15
Detry JM, Block P, De Backer G, Degaute JP (1995) Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group. Eur J Clin Pharmacol 47:477–481
Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23:1296–1310
Stewart RB, Cluff LE (1972) A review of medication errors and compliance in ambulant patients. Clin Pharmacol Ther 13:463–468
Krueger KP, Berger BA, Felkley B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22:319–362
Ziessler M, Mehlhorn J, Zimmermann S (1990) Drug taking behavior of internal medicine inpatients. Z Ges Inn Med 45:158–161
Johnell K, Klarin I (2007) The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911–918
Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) Locus: sequence and identification of the polymorphic CYP2D6 gene, al related gene, and a pseudogene. Am J Hum Genet 45:889–904
Johansson I, Lundquist E, Bertilsson L, Dahl MJ, Sjöquist F, Ingelmann-Sundberg M (1993) Inherited amplification of an active gene in he cytochrome P450 CYP2D6 locus as a cause of ultrarapid metabolism of debrisoquine. Proc Natl Acad Sci USA 90:11825–11829
Warne S, Endacott R, Ryan H, Chamberlain W, Hendry J, Boulanger C, Donlin N (2010) Non-therapeutic omission of medications in acutely ill patients. Nurs Crit Care 15:112–117
Bertsche T, Niemann D, Mayer Y, Ingram K, Hoppe-Tichy T, Haefeli WE (2008) Prioritising the prevention of medication handling errors. Pharm World Sci 30:907–915
Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR (2001) Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol 54:553–555
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carow, F., Rieger, K., Walter-Sack, I. et al. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. Eur J Clin Pharmacol 68, 1191–1199 (2012). https://doi.org/10.1007/s00228-012-1229-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1229-2